Opvee® (nalmefene) – New drug approval
May 23, 2023 - Indivior announced the FDA approval of Opvee (nalmefene), for the emergency treatment of known or suspected overdose induced by natural or synthetic opioids in adults and pediatric patients aged 12 years and older, as manifested by respiratory and/or central nervous system depression.
Top